Minoxidil in the Management of Androgenetic Alopecia: Mechanisms of Action, Clinical Efficacy, and Emerging Formulations

Authors

  • Khalid Mohamed, Heba Mohammed, Esraa Ezzat Abo El Ella Elsayed Author

DOI:

https://doi.org/10.48047/qgev7y30

Keywords:

Minoxidil, Management, Androgenetic Alopecia

Abstract

Background: Androgenetic alopecia (AGA) is the most prevalent form of non-scarring hair loss and a chronic, progressive disorder 
characterized by follicular miniaturization, shortened anagen duration, and patterned thinning in men and women. The condition carries a substantial psychosocial burden and often requires long-term therapy to preserve gains. Pathophysiologically, AGA reflects an interplay between genetic susceptibility and androgen signaling, particularly the effects of dihydrotestosterone on androgen-sensitive scalp follicles, with downstream dysregulation of dermal papilla function,

Downloads

Download data is not yet available.

References

Brzezińska-Wcisło L, Rakowska A, Rudnicka L, Bergler-Czop B, Czuwara J, Maj J. Androgenetic alopecia: diagnostic and therapeutic recommendations of the Polish Dermatological Society. Dermatol Rev. 2018;105(1):1–18.

Starace M, Orlando G, Alessandrini A, Piraccini BM. Female androgenetic alopecia: an update on diagnosis and management. Am J Clin Dermatol. 2020;21(1):69–84

Downloads

Published

2024-11-20

How to Cite

Minoxidil in the Management of Androgenetic Alopecia: Mechanisms of Action, Clinical Efficacy, and Emerging Formulations (Khalid Mohamed, Heba Mohammed, Esraa Ezzat Abo El Ella Elsayed , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 6751-6758. https://doi.org/10.48047/qgev7y30